(Q39805075)

14 September 2017

title

Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome (English)

1 reference

14 September 2017

1 reference

Loredan Stefan Niculescu

1

1 reference

14 September 2017

Jamila Fruchart-Najib

2

1 reference

14 September 2017

Jean-Charles Fruchart

3

1 reference

14 September 2017

Anca Sima

4

1 reference

14 September 2017

publication date

1 January 2007

1 reference

Clinical Chemistry and Laboratory Medicine

14 September 2017

published in

1 reference

14 September 2017

volume

45

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

1133-1139

1 reference

14 September 2017

cites work

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

New risk factors for atherosclerosis and patient risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Evidence that triglycerides are an independent coronary heart disease risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Structure and interfacial properties of human apolipoprotein A-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Determination of the functionality of common APOA5 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

Prediction of genetic risk for metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

The −1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.257

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.257

1 reference

14 September 2017

1 reference